Notably, the novel dual PI3K/MTOR inhibitor NVP-BGT226 reveals extraordinary potency to inhibit proliferation as well as to induce apoptosis in the nanomolar range against a broad range of cell lines and ex vivo leukemia samples tested. This evidence concerns the gene MTOR and leukemia.